News

The Market Herald – Proteomics (ASX:PIQ) partners up with QIMR Berghofer Institute

The blood test will help to improve the detection of oesophageal adenocarcinoma, Australia’s most common form of oesophageal cancer.

When offered to people who are predisposed to oesophageal cancer, the test may help reduce invasive, risky and expensive endoscopies.

Article: Proteomics (ASX:PIQ) partners up with QIMR Berghofer Institute

Subscribe
  • This field is for validation purposes and should be left unchanged.